To date, evidence on the dose adjustments of biologics in the real‐world treatment of psoriasis is limited. However, dose adjustments may have important clinical and economic implications. Click to show full abstract
To date, evidence on the dose adjustments of biologics in the real‐world treatment of psoriasis is limited. However, dose adjustments may have important clinical and economic implications.
               
Click one of the above tabs to view related content.